Dr Edward R Scheffer Cliff
Clinical (Lecturer)
The Sir Peter MacCallum Department of Oncology
51 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma
DOI: 10.1016/j.ymthe.2025.03.0482025
Journal article
Changes in Oncology Medication Use after Withdrawal of Accelerated Approval
DOI: 10.1001/jamaoncol.2025.03592025
Journal article
Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study
DOI: 10.1016/j.eclinm.2025.1030882025
Journal article
Medicare spending and use of subcutaneous biologic formulations with hyaluronidase
DOI: 10.1093/oncolo/oyaf1492025
Other
AI Devices in Neurology - Moving From Diagnosis to Prognosis
DOI: 10.1001/jamaneurol.2024.38352025
Journal article
Financial challenges of being on long-Term, high-cost medications
DOI: 10.1093/nop/npae0982021
Journal article
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
DOI: 10.1182/bloodadvances.2021005083
RECENT SCHOLARLY WORKS
2025
Journal article
Advancing Global Pharmacoequity in Oncology
DOI: 10.1001/jamaoncol.2024.50322024
Journal article
The lucent yet opaque challenge of regulating artificial intelligence in radiology
DOI: 10.1038/s41746-024-01071-22024
Journal article
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma
DOI: 10.1038/s41408-024-01114-72024
Journal article
US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma
DOI: 10.1200/JCO.24.00100